Home
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Find a Pharmacy
Health News
Medications
Conditions
RxCoupons
Pharmacy Solutions
Health News
FDA Approves Drug for Acute Coronary Syndromes
The U.S. Food and Drug Administration today approved the blood-thinning drug Brilinta ( ticagrelor ) to reduce cardiovascular death and heart attack in patients with acute coronary syndromes (ACS).
REFINE
medications
Remove Brilinta filter
(-)
Remove Brilinta filter
Brilinta
conditions
Apply Cardiovascular filter
Cardiovascular (1)
Apply Cardiovascular filter
Apply Atherosclerosis filter
Atherosclerosis (1)
Apply Atherosclerosis filter
Apply Heart Attack filter
Heart Attack (1)
Apply Heart Attack filter
Apply High Cholesterol filter
High Cholesterol (1)
Apply High Cholesterol filter